GM21912
LCL from B-Lymphocyte
Description:
RETT SYNDROME; RTT
METHYL-CPG-BINDING PROTEIN 2; MECP2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
MECP2 |
Chromosomal Location |
Xq28 |
Allelic Variant 1 |
300005.0005; RETT SYNDROME |
Identified Mutation |
ARG270TER; In 3 of 31 patients with Rett syndrome (312750), Huppke et al. (Hum Molec Genet 9:1369-1375,2000) identified an 808C-T transition in the MECP2 gene, resulting in a premature stop codon (arg270-to-ter; R270X) in exon 3. Bienvenu et al. (Hum Molec Genet 9:1377-1384,2000) found the same mutation in 5 of 46 Rett syndrome patients studied. De Bona et al. (Europ J Hum Genet 8:325-330,2000) identified the R270X mutation in 4 unrelated individuals with Rett syndrome, indicating that it represents a hotspot. |
Remarks |
Clinically affected; donor subject has a C>T transition at nucleotide 808 in exon 3 of the MECP2 gene (808C>T) resulting in a premature stop codon [Arg270Ter (R270X)] |
Sung Jae Lee S, Wan M, Francke U, Spectrum of MECP2 mutations in Rett syndrome. Brain Dev23 Suppl 1:S138-43 2001 |
PubMed ID: 11738860 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|